Nutrien Ltd.

NYSE:NTR 株式レポート

時価総額：US$37.5b

Nutrien 過去の業績

過去 基準チェック /46

Nutrienの収益は年間平均-23.8%の割合で減少していますが、 Chemicals業界の収益は年間 減少しています。収益は年間2.9% 3%割合で 減少しています。 Nutrienの自己資本利益率は9.3%であり、純利益率は8.7%です。

主要情報

-23.80%

収益成長率

-20.57%

EPS成長率

Chemicals 業界の成長12.93%
収益成長率-3.02%
株主資本利益率9.29%
ネット・マージン8.72%
次回の業績アップデート05 Nov 2026

最近の業績更新

Recent updates

Seeking Alpha • Aug 31

Nutrien: Lowering To A Hold On Mixed Q2 (Rating Downgrade)

Summary Nutrien is lowered to a Hold after a mixed Q2, as higher sales were accompanied by weaker profitability, lower fertilizer volumes, and higher sulfur costs. Long-term fertilizer demand remains tied to crop production, but that does not remove the cyclicality of Nutrien’s earnings. Near-term uncertainty remains in nitrogen, phosphate, and Retail, while potash performed better and the lower end of 2026 potash volume guidance was raised. Nutrien trades below the sector on several forward valuation measures, but above its own five-year averages, limiting the margin of safety at the current valuation. Read the full article on Seeking Alpha
Seeking Alpha • Feb 24

Nutrien: The Downtrend Is Done, Dividend Hike And Technicals Are Evidence

Summary The Materials sector, particularly the agricultural industry, has outperformed in 2025, with the Global X AgTech & Food Innovation ETF leading the way. Nutrien offers value with an attractive yield, improved Q4 performance, and bullish technical signals suggesting a potential rise to $70. Despite mixed Q4 results, Nutrien's positive outlook, cost-cutting efforts, and high dividend yield underscore cautious optimism and potential EPS upgrades. Key risks include retail competition, global macro weakness, geopolitical tensions, and weather impacts, but the technical breakout and valuation support a buy rating. Read the full article on Seeking Alpha
Seeking Alpha • Dec 11

Nutrien: Worth Having Exposure To

Summary Nutrien Ltd. offers a strong market presence and cost advantages in potash and nitrogen, making it a compelling value despite cyclical fertilizer price volatility. The stock's 4.4% dividend yield and nearly 10% free cash flow yield provide an attractive income that is well-covered at low fertilizer prices. Nutrien's conservative capital allocation during cycles and recent performance as an inflation hedge enhance its potential to enhance risk-adjusted returns in upcoming inflation shocks. Technical analysis suggests the potential for a breakout, especially if fertilizer prices surprise to the upside; current valuation and dividend yield make it a compelling value investment. Read the full article on Seeking Alpha
Seeking Alpha • Nov 12

Growth On The Cheap: Nutrien's Big Yield In Fertile Ground

Summary Nutrien Ltd., the world's largest potash producer, has a narrow-moat advantage, allowing profitability even when commodity prices are low. Despite recent volatility, Nutrien's 3Q24 data shows promising growth, with EBITDA up 21%, supported by higher prices and sales volumes. My investment thesis remains strong; Nutrien is a "Strong Buy" due to its cost advantages and potential for recovery in agricultural markets. Read the full article on Seeking Alpha
Seeking Alpha • Oct 04

Nutrien: An Underappreciated Hedge Against Resurgent Supply-Side Inflation Risks

Summary Fertilizer prices have stabilized to pre-COVID levels, with stocks like Nutrien trading as if the supply-chain spike never occurred. Fertilizer producers are an overlooked inflation hedge due to their strong correlation with natural gas and crop prices, with North American export demand growing. Nutrien's valuation is down, but it may be an accumulation opportunity with potential supply-side pressures seemingly rebounding. Although low domestic crop prices are a risk, Nutrien's recession exposure is low, and its correlation to the S&P 500 is very low at ~0.3X, making it a long-term alpha play. Read the full article on Seeking Alpha
Seeking Alpha • Sep 15

Nutrien: Short-Termism Creates Opportunities For Long-Term Investors (Rating Upgrade)

Summary Nutrien's share price has continued sliding over the course of 2024, but margin and sales headwinds are weakening. The company is well-positioned to serve the high margin North America market while also expending in Latin America. At the same time, the assumptions that are built in the share price are unlikely to persist beyond the near term. Investors should be prepared for more volatility ahead, but a rating upgrade appears justified at this point in time. Read the full article on Seeking Alpha
Seeking Alpha • Aug 20

Nutrien Remains A 'Strong Buy' As The Tide Is Turning

Summary Nutrien's stock has declined due to low crop prices, high inflation, and interest rates, but its strong financials hint at a bottoming trend. The company’s cost management and strong performance in key segments show resilience, with a positive long-term outlook driven by rising demand. Despite past struggles, I maintain a Strong Buy rating on Nutrien, confident in its potential rebound as market conditions improve. Read the full article on Seeking Alpha
Seeking Alpha • Jul 10

Nutrien: We Could See A Reversal In 2024

Summary Nutrien's stock price continued falling in the first half of 2024, mostly in line with agricultural commodities. At the same time, however, certain business fundamentals are showing early signs of recovery. The stock now trades at significantly more attractive levels and long-term investors should take notice. Read the full article on Seeking Alpha
Seeking Alpha • May 06

Nutrien: A Low-Risk Total Return Pick Benefiting From Inflation

Summary Nutrien share pricing has returned to 2018 levels, despite a stronger balance sheet and greater underlying asset value. The company offers a solid 4% dividend yield, making it an attractive choice for investors looking for both income and food-inflation hedge characteristics. With a resilient farm economy and the potential for oversized grain advances, Nutrien buyers may experience above-average total return performance over the next 3-5 years. Read the full article on Seeking Alpha
Seeking Alpha • Feb 22

Nutrien: I'm Buying More Before The Market Finds Out How Cheap It Is

Summary Nutrien has experienced a decline in stock price following the decrease in net earnings and adjusted EBITDA in 2023. Despite the headwinds, Nutrien remains committed to returning value to shareholders through increased dividends and share repurchases. The company anticipates higher fertilizer sales volumes and improved metrics in 2024, supported by strong potash demand and positive market conditions. Read the full article on Seeking Alpha
Seeking Alpha • Feb 13

Ho Ho Ho Green Giant: Nutrien Ltd. And CF Industries Holdings

Summary Soft commodities are bottoming at higher lows, leading to increased food prices. Nutrien is the largest global retailer of fertilizer and has been expanding through acquisitions. CF Industries Holdings is adjusting its business strategy and has significant cash to buy stock at depressed prices. A technical EW view of these fertilizer giants. Read the full article on Seeking Alpha
Seeking Alpha • Jan 19

Nutrien: Patience Will Award Shareholders

Summary Nutrien's 2023 results show a decline in gross margin and net profit compared to previous years. The company's guidance for 2023 indicates a need for approximately $2.1-2.2 billion in sustaining capital expenditures (and leases). Nutrien's long-term outlook suggests a normalized EBITDA of $7-7.5 billion per year, providing potential for higher free cash flows. Read the full article on Seeking Alpha

収支内訳

Nutrien の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。

収益と収入の歴史

NYSE:NTR 収益、費用、利益 ( )USD Millions
日付収益収益G+A経費研究開発費
30 Jun 2627,2882,3804,1960
31 Mar 2626,8772,3874,2150
31 Dec 2525,9492,2674,0870
30 Sep 2525,6711,8094,0800
30 Jun 2525,0211,3634,0900
31 Mar 2524,7395274,1180
31 Dec 2425,0166744,1210
30 Sep 2425,5567334,2070
30 Jun 2425,8397904,2220
31 Mar 2427,3258454,1180
31 Dec 2328,0821,2584,0940
30 Sep 2329,9672,1983,9490
30 Jun 2332,5833,7003,9590
31 Mar 2335,4666,8533,9920
31 Dec 2237,0127,6604,0500
30 Sep 2236,7927,7494,1800
30 Jun 2234,6126,8894,1010
31 Mar 2229,8684,4044,0150
31 Dec 2126,8613,1533,8260
30 Sep 2123,6422,2683,6630
30 Jun 2121,8619643,5520
31 Mar 2120,5146213,4090
31 Dec 2020,0534593,3240
30 Sep 2019,534953,2130
30 Jun 2019,4708233,0840
31 Mar 2019,7549163,0520
31 Dec 1919,3169923,0280
30 Sep 1919,6711,3362,8890
30 Jun 1919,4491282,9290
31 Mar 1918,862112,9300
31 Dec 1818,772-312,8910
30 Sep 1816,051-4472,2980
30 Jun 1813,3766361,6310
31 Mar 186,489478290
31 Dec 174,0101542330
30 Sep 173,9731962180
30 Jun 173,8932612210
31 Mar 173,8242302330
31 Dec 163,9211992310
30 Sep 164,2394782530
30 Jun 164,6586792460
31 Mar 165,3309752510
31 Dec 155,7911,1152580
30 Sep 156,3031,4762580

質の高い収益: NTRは 高品質の収益 を持っています。

利益率の向上: NTRの現在の純利益率 (8.7%)は、昨年(5.4%)よりも高くなっています。

フリー・キャッシュフローと収益の比較

過去の収益成長分析

収益動向: NTRの収益は過去 5 年間で年間23.8%減少しました。

成長の加速: NTRの過去 1 年間の収益成長率 ( 74.6% ) は、5 年間の平均 ( 年間-23.8%を上回っています。

収益対業界: NTRの過去 1 年間の収益成長率 ( 74.6% ) はChemicals業界2.4%を上回りました。

株主資本利益率

高いROE: NTRの 自己資本利益率 ( 9.3% ) は 低い とみなされます。

総資産利益率

使用総資本利益率

過去の好業績企業の発掘

7D

1Y

7D

1Y

7D

1Y

企業分析と財務データの現状

データ最終更新日（UTC時間）
企業分析2026/09/11 15:00
終値2026/09/11 00:00
収益2026/06/30
年間収益2025/12/31

データソース

企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。

パッケージデータタイムフレーム米国ソース例
会社財務10年
  • 損益計算書
  • キャッシュ・フロー計算書
  • 貸借対照表
アナリストのコンセンサス予想+プラス3年
  • 予想財務
  • アナリストの目標株価
市場価格30年
  • 株価
  • 配当、分割、措置
所有権10年
  • トップ株主
  • インサイダー取引
マネジメント10年
  • リーダーシップ・チーム
  • 取締役会
主な進展10年
  • 会社からのお知らせ

* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。

特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。

分析モデルとスノーフレーク

このレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。

シンプリー・ウォールストリート分析モデルを設計・構築した ご紹介します。

業界およびセクターの指標

私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。

アナリスト筋

Nutrien Ltd. 16 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。51

アナリスト機関
Harriet LiAccountability Research Corporation
Keith CarpenterATB Cormark
Benjamin TheurerBarclays